-

$undefined

N/A

(N/A)

Genmab NASDAQ:GMAB Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund.

Location: Koebenhavn V, 1560, Denmark | Website: http://www.genmab.com/ | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing

Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

-18.65B

Cash

21.1B

Avg Qtr Burn

N/A

Short % of Float

2.58%

Insider Ownership

0.03%

Institutional Own.

9.32%

Qtr Updated

12/31/24

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Epkinly (epcoritamab) Details Follicular lymphoma, Cancer	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.